Effect of Purendan Superfine Powder on IRS-1, PI3K, GLUT4,NF-κB Protein Expression of Skeletal Muscles in Type 2 Diabetic Mellitus Rats with Macroangiopathy

LU Bi-nan,SU Zhan-hui,SU Xiao-hui,WANG Zhao-hui,LIU Zu-han,PANG Zong-ran
DOI: https://doi.org/10.11653/syfj2013090210
2013-01-01
Abstract:Objective:To explore the molecular mechanisms of Purendan superfine powder(PRD)on metabolic disorder and the protection on macroangiopathy by investigating the protein expression of insulin receptor substrate-1(IRS-1),phosphatidylinositol 3-kinase(PI3K),glucose transporter 4(GLUT4) and nuclear factor-κB(NF-κB) of skeletal muscles in type 2 diabetes mellitus(T2DM) rats with macroangiopathy.Method: High-fat-diet/streptozotocin(STZ,30 mg · kg-1)-induced type 2 diabetes mellitus rats were developed and treated with PRD(0.885,1.770,3.540 g · kg-1) for four weeks and rosiglitazone(0.36×10-3 g · kg-1) was used as positive control drugs,then western blot assay was used to analyze the protein expression of IRS-1,PI3K,GLUT 4 and NF-κB of skeletal muscle in the rats.Result: The protein expression of IRS-1,PI3K and GLUT-4 was significantly decreased in T2DM group compared with the control group(P0.01),while NF-κB expression was significantly increased(P0.01).After the treatment of PRD,the expression of IRS-1,PI3K and GLUT-4 was up-regulated,and NF-κB was down-regulated significantly(P0.05 or P0.01),which was equivalent to the positive drugs.Conclusion: PRD could improve insulin resistance,decrease blood glucose and fat,protect the vascular endothelium injury by up-regulating IRS-1,PI-3K and GLUT 4 protein expression and down-regulating NF-κB protein expression of skeletal muscle in T2DM rats.
What problem does this paper attempt to address?